Linzess - 0456-1202-30 - (linaclotide)

Alphabetical Index


Drug Information of Linzess

Product NDC: 0456-1202
Proprietary Name: Linzess
Non Proprietary Name: linaclotide
Active Ingredient(s): 290    ug/1 & nbsp;   linaclotide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Linzess

Product NDC: 0456-1202
Labeler Name: Forest Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202811
Marketing Category: NDA
Start Marketing Date: 20120908

Package Information of Linzess

Package NDC: 0456-1202-30
Package Description: 1 BOTTLE in 1 CARTON (0456-1202-30) > 30 CAPSULE, GELATIN COATED in 1 BOTTLE

NDC Information of Linzess

NDC Code 0456-1202-30
Proprietary Name Linzess
Package Description 1 BOTTLE in 1 CARTON (0456-1202-30) > 30 CAPSULE, GELATIN COATED in 1 BOTTLE
Product NDC 0456-1202
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name linaclotide
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 20120908
Marketing Category Name NDA
Labeler Name Forest Laboratories, Inc.
Substance Name LINACLOTIDE
Strength Number 290
Strength Unit ug/1
Pharmaceutical Classes Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA]

Complete Information of Linzess


General Information